Smear-positive tuberculosis treatment-success rate in Upper-middle income (World Bank)
Upper-middle income (World Bank): Smear-positive tuberculosis treatment-success rate was 87.0% in 2011. ▲ Rising
Latest (2011)
87.0%
Change on year
unchanged
Rank
5th
of 10 groups
All-time high
87.0%
in 2007
All-time low
70.0%
in 1995
Years of data
18
1994–2011
Smear-positive tuberculosis treatment-success rate in Upper-middle income (World Bank), 1994–2011
Source: World Health Organization, Global Health Observatory.
Analysis
In 2011, smear-positive tuberculosis treatment-success rate in Upper-middle income (World Bank) stood at 87.0%. That is the highest value across all 18 years on record.
The figure is up 10.1% over ten years.
Over the whole period, smear-positive tuberculosis treatment-success rate in Upper-middle income (World Bank) peaked at 87.0% in 2007 and was at its lowest, 70.0%, in 1995.
The long-run direction has been consistently rising across the 18 years of available data.
Smear-positive tuberculosis treatment-success rate in Upper-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 1994 | 78.0% | — |
| 1995 | 70.0% | -10.3% |
| 1996 | 73.0% | +4.3% |
| 1997 | 77.0% | +5.5% |
| 1998 | 81.0% | +5.2% |
| 1999 | 83.0% | +2.5% |
| 2000 | 81.0% | -2.4% |
| 2001 | 79.0% | -2.5% |
| 2002 | 82.0% | +3.8% |
| 2003 | 82.0% | +0.0% |
| 2004 | 84.0% | +2.4% |
| 2005 | 86.0% | +2.4% |
| 2006 | 84.0% | -2.3% |
| 2007 | 87.0% | +3.6% |
| 2008 | 87.0% | +0.0% |
| 2009 | 87.0% | +0.0% |
| 2010 | 87.0% | +0.0% |
| 2011 | 87.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 77.0% | 70.0% | 83.0% | 6 |
| 2000s | 83.9% | 79.0% | 87.0% | 10 |
| 2010s | 87.0% | 87.0% | 87.0% | 2 |
Countries ranked near Upper-middle income (World Bank)
- 7 Oman 97.0% compare
- 8 Micronesia, Federated States of 96.0% compare
More health data for Upper-middle income (World Bank)
- Measles - number of reported cases, gaps filled 91,627 (2025)
- Diphtheria - number of reported cases, gaps filled 1,556 (2025)
- Total tetanus - number of reported cases, gaps filled 5,773 (2025)
- Pertussis - number of reported cases, gaps filled 63,803 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 212 (2025)
- Number of under-five deaths, annual growth rate -6.19 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -4.24 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.78 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -27.52 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -87.69 % change on previous year (2025)
Frequently asked questions
- What is smear-positive tuberculosis treatment-success rate in Upper-middle income (World Bank)?
- Smear-positive tuberculosis treatment-success rate in Upper-middle income (World Bank) was 87.0% in 2011, according to World Health Organization, Global Health Observatory.
- What is the highest smear-positive tuberculosis treatment-success rate recorded in Upper-middle income (World Bank)?
- The highest recorded value was 87.0% in 2007.
- What is the lowest smear-positive tuberculosis treatment-success rate recorded in Upper-middle income (World Bank)?
- The lowest recorded value was 70.0% in 1995.
- How does Upper-middle income (World Bank) rank for smear-positive tuberculosis treatment-success rate?
- Upper-middle income (World Bank) ranks 5th out of 10 groups with data for 2011.
- Is smear-positive tuberculosis treatment-success rate rising or falling in Upper-middle income (World Bank)?
- Over the last ten years it is up 10.1%. The long-run trend across the full record is rising.
- Where does this Upper-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Smear-positive tuberculosis treatment-success rate (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).